The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients

[1]  J. Wetterslev,et al.  Lower vs Higher Fluid Volumes During Initial Management of Sepsis , 2020, Chest.

[2]  J. D. Young,et al.  Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial. , 2020, JAMA.

[3]  A. Duggal,et al.  Association Between Volume of Fluid Resuscitation and Intubation in High Risk Septic Patients with Heart Failure, End Stage Renal Disease and Cirrhosis. , 2020, Chest.

[4]  J. Wetterslev,et al.  Lower versus higher fluid volumes during initial management of sepsis - a systematic review with meta-analysis and trial sequential analysis. , 2020, Chest.

[5]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids Versus Saline in Sepsis: A Secondary Analysis of the SMART Trial. , 2019, American journal of respiratory and critical care medicine.

[6]  P. V. Van Schil,et al.  154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial , 2019, Intensive Care Medicine.

[7]  J. Bakker,et al.  Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients with Septic Shock: A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial. , 2019, American journal of respiratory and critical care medicine.

[8]  M. Rech,et al.  Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis , 2019, The Annals of pharmacotherapy.

[9]  G. Martin,et al.  Lactated Ringer's Versus 4% Albumin on Lactated Ringer's in Early Sepsis Therapy in Cancer Patients: A Pilot Single-Center Randomized Trial. , 2019, Critical care medicine.

[10]  M. Plana,et al.  Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children. , 2019, The Cochrane database of systematic reviews.

[11]  Shutang Han,et al.  Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials , 2019, Critical Care.

[12]  J. Takala,et al.  Fluid management in patients undergoing cardiac surgery: effects of an acetate- versus lactate-buffered balanced infusion solution on hemodynamic stability (HEMACETAT) , 2019, Critical Care.

[13]  K. Akers,et al.  Resuscitation Guided by Volume Responsiveness Does Not Reduce Mortality in Sepsis: A Meta-Analysis , 2019, Critical care explorations.

[14]  G. Martin,et al.  Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta‐analysis , 2019, Journal of critical care.

[15]  J. Bakker,et al.  Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial , 2019, JAMA.

[16]  Yi Yang,et al.  Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: a meta-analysis with trial sequential analysis of randomized trials , 2019, Annals of Intensive Care.

[17]  Thomas W. L. Scheeren,et al.  Current use of vasopressors in septic shock , 2019, Annals of Intensive Care.

[18]  L. Morrison,et al.  Association Between Early Intravenous Fluids Provided by Paramedics and Subsequent In-Hospital Mortality Among Patients With Sepsis , 2018, JAMA network open.

[19]  S. Lemeshow,et al.  Mortality Changes Associated with Mandated Public Reporting for Sepsis. The Results of the New York State Initiative , 2018, American journal of respiratory and critical care medicine.

[20]  J. Bakker,et al.  Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force , 2018, Intensive Care Medicine.

[21]  M. Levy,et al.  Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock , 2018, Critical care medicine.

[22]  M. Levy,et al.  Surviving sepsis campaign: research priorities for sepsis and septic shock , 2018, Intensive Care Medicine.

[23]  M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 Update. , 2018, Critical care medicine.

[24]  R. Bellomo,et al.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II , 2018, Critical care medicine.

[25]  C. Seymour,et al.  Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial* , 2018, Critical care medicine.

[26]  Mitchell M. Levy,et al.  The Surviving Sepsis Campaign Bundle: 2018 update , 2018, Intensive Care Medicine.

[27]  M. Mazer-Amirshahi,et al.  Saline Shortages - Many Causes, No Simple Solution. , 2018, The New England journal of medicine.

[28]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids versus Saline in Critically Ill Adults , 2018, Journal Club AINS.

[29]  J. Vincent,et al.  Should we measure the central venous pressure to guide fluid management? Ten answers to 10 questions , 2018, Critical Care.

[30]  Daniel W. Johnson.  Comparison of Dopamine and Norepinephrine in the Treatment of Shock , 2018 .

[31]  J. Meier,et al.  Angiotensin II for the Treatment of Vasodilatory Shock. , 2017, The New England journal of medicine.

[32]  M. Doerfler,et al.  Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort* , 2017, Critical care medicine.

[33]  S. Lemeshow,et al.  Time to Treatment and Mortality during Mandated Emergency Care for Sepsis , 2017, The New England journal of medicine.

[34]  R. Bellomo,et al.  Angiotensin II for the Treatment of Vasodilatory Shock , 2017, The New England journal of medicine.

[35]  H. Gershengorn,et al.  Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock , 2017, JAMA.

[36]  J. Marshall,et al.  Higher Fluid Balance Increases the Risk of Death From Sepsis: Results From a Large International Audit* , 2017, Critical care medicine.

[37]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[38]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[39]  M. Meade,et al.  Vasopressor Use for Severe Hypotension—A Multicentre Prospective Observational Study , 2017, PloS one.

[40]  T. Rice,et al.  Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock , 2017, The Annals of pharmacotherapy.

[41]  Jørn Wetterslev,et al.  Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial , 2016, Intensive Care Medicine.

[42]  M. Doerfler,et al.  Association of Fluid Resuscitation Initiation Within 30 Minutes of Severe Sepsis and Septic Shock Recognition With Reduced Mortality and Length of Stay. , 2016, Annals of emergency medicine.

[43]  J. Vincent,et al.  Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed? , 2016, Critical Care.

[44]  G. Perkins,et al.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. , 2016, JAMA.

[45]  A. Perner,et al.  Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness , 2016, Intensive Care Medicine.

[46]  R. Bellomo,et al.  Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. , 2015, JAMA.

[47]  Leonard Leibovici,et al.  Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis , 2015, PloS one.

[48]  M. Cecconi,et al.  Fluid challenges in intensive care: the FENICE study , 2015, Intensive Care Medicine.

[49]  J. Wetterslev,et al.  Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis , 2015, Acta anaesthesiologica Scandinavica.

[50]  S. Lemeshow,et al.  Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study , 2014, Intensive Care Medicine.

[51]  C. Callaway,et al.  Prehospital intravenous access and fluid resuscitation in severe sepsis: an observational cohort study , 2014, Critical Care.

[52]  F. Machado,et al.  Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation , 2014, Annals of Intensive Care.

[53]  Claude Guerin,et al.  High versus low blood-pressure target in patients with septic shock. , 2014, The New England journal of medicine.

[54]  M. Antonelli,et al.  Albumin replacement in patients with severe sepsis or septic shock. , 2014, The New England journal of medicine.

[55]  A. Perner,et al.  Understanding hypovolaemia , 2014, Intensive Care Medicine.

[56]  G. Escobar,et al.  Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. , 2013, Annals of the American Thoracic Society.

[57]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[58]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[59]  V. Pilvinis,et al.  Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy , 2012, Intensive Care Medicine.

[60]  D. Chemla,et al.  Effects of norepinephrine on mean systemic pressure and venous return in human septic shock* , 2012, Critical care medicine.

[61]  Michael Bailey,et al.  Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. , 2012, JAMA.

[62]  G. Guyatt,et al.  Vasopressor administration and sepsis: a survey of Canadian intensivists. , 2011, Journal of critical care.

[63]  K. Walley,et al.  Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality* , 2011 .

[64]  D. Benhamou,et al.  Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients , 2010, Intensive Care Medicine.

[65]  C. Richard,et al.  Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension , 2010, Critical care.

[66]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[67]  J. Vincent,et al.  Effects of fluids on microvascular perfusion in patients with severe sepsis , 2010, Intensive Care Medicine.

[68]  T. Rea,et al.  Out-of-Hospital Fluid in Severe Sepsis: Effect on Early Resuscitation in the Emergency Department , 2010, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[69]  J. Parrillo,et al.  Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis , 2009, Intensive Care Medicine.

[70]  M. Westphal,et al.  Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial , 2008, Critical care.

[71]  Therapy Study Investigators,et al.  A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.

[72]  Sangeeta Mehta,et al.  Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.

[73]  D. Annane,et al.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial , 2007, The Lancet.

[74]  P. Lacolley,et al.  Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock* , 2007, Critical care medicine.

[75]  Robyn Norton,et al.  A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .

[76]  A. Oldner,et al.  A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units , 2003, Acta anaesthesiologica Scandinavica.

[77]  J. Parrillo,et al.  Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. , 2001, American journal of respiratory and critical care medicine.

[78]  S. Shroff,et al.  Alterations in systemic arterial mechanical properties during septic shock: role of fluid resuscitation. , 1995, The American journal of physiology.

[79]  M. Haupt,et al.  The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. , 1986, The American review of respiratory disease.

[80]  J. Vincent,et al.  Acetate-induced myocardial depression during hemodialysis for acute renal failure. , 1982, Kidney international.

[81]  Y. Aizawa,et al.  Depressant action of acetate upon the human cardiovascular system. , 1977, Clinical nephrology.

[82]  W. Self,et al.  Balanced Crystalloids versus Saline in Sepsis A Secondary Analysis of the SMART Clinical Trial , 2019 .

[83]  Jesse M. Ehrenfeld,et al.  Balanced Crystalloids versus Saline in Noncritically Ill Adults , 2018, The New England journal of medicine.

[84]  G. Guyatt,et al.  Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock , 2017, Intensive Care Medicine.

[85]  S. Lemeshow,et al.  Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. , 2015, Critical care medicine.

[86]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2008 .